By John Gruber
WorkOS, the modern identity platform for B2B SaaS — free up to 1 million MAUs.
Om Malik:
From Business Insider (which called it iPhone of e-cigarettes) to CrunchBase, everyone seems to marvel over their growth rates, their post-Unicorn valuations, and jaw-dropping success at raising capital. And very rarely have I seen anyone stand up and point out that it is no different than traditional tobacco peddlers like Marlboro and Camel. They are peddling nicotine-based addiction. By focusing on charming founders, their backgrounds, large amount of funds raised and crazy valuations, no one is asking the right question: why are we supporting this company that is essentially Camel 2.0?
Addiction is a profitable and high-growth business. Ask the cartels selling other addictive products. “And is it an ethical business?,” asks Crunchbase. “We can’t answer the latter question here as we’re not equipped for it.” Yes, you are! Any halfway decent person can see that tobacco and nicotine industries are driven by greed and have preyed on human frailty.
Agree with every word of this.
★ Thursday, 26 July 2018